| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |